Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
Atossa Therapeutics Inc (NASDAQ: ATOS) closed the day trading at $0.63 up 6.88% from the previous closing price of $0.59. In other words, the price has increased by $6.88 from its previous closing price. On the day, 1.51 million shares were traded. ATOS stock price reached its highest trading level at $0.6339 during the session, while it also had its lowest trading level at $0.5926.
Ratios:
For a better understanding of ATOS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.77 and its Current Ratio is at 6.77. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, Maxim Group on January 26, 2018, initiated with a Buy rating and assigned the stock a target price of $2.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 21 ’25 when QUAY STEVEN C bought 11,239 shares for $0.88 per share. The transaction valued at 9,887 led to the insider holds 13,898 shares of the business.
Remmel H. Lawrence bought 10,000 shares of ATOS for $7,000 on Mar 26 ’25. The Director now owns 10,257 shares after completing the transaction at $0.70 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATOS now has a Market Capitalization of 81455496 and an Enterprise Value of 29610500.
Stock Price History:
The Beta on a monthly basis for ATOS is 1.10, which has changed by -0.34375 over the last 52 weeks, in comparison to a change of 0.14778805 over the same period for the S&P500. Over the past 52 weeks, ATOS has reached a high of $1.29, while it has fallen to a 52-week low of $0.55. The 50-Day Moving Average of the stock is -19.66%, while the 200-Day Moving Average is calculated to be -22.69%.
Shares Statistics:
Over the past 3-months, ATOS traded about 1.11M shares per day on average, while over the past 10 days, ATOS traded about 1412540 shares per day. A total of 129.17M shares are outstanding, with a floating share count of 129.10M. Insiders hold about 0.06% of the company’s shares, while institutions hold 19.41% stake in the company. Shares short for ATOS as of 1765756800 were 2284050 with a Short Ratio of 2.06, compared to 1763078400 on 1379122. Therefore, it implies a Short% of Shares Outstanding of 2284050 and a Short% of Float of 2.0.
Earnings Estimates
The market rating for Atossa Therapeutics Inc (ATOS) is a result of the insights provided by 3.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.07, with high estimates of -$0.06 and low estimates of -$0.08.
Analysts are recommending an EPS of between -$0.24 and -$0.26 for the fiscal current year, implying an average EPS of -$0.25. EPS for the following year is -$0.29, with 3.0 analysts recommending between -$0.26 and -$0.32.
